Drug intelligence / Profile preview

terbutaline + bromhexine + guaifenesin + menthol

Development stage
Unknown
Lead developer
Skyways Healthcare
Modality
Small Molecules
Administration
Oral
01

Overview

Vocuff-BR is a combination cough syrup marketed by Skyways Healthcare, primarily used for the treatment of productive cough associated with conditions such as bronchitis, bronchial asthma, and emphysema. It contains four active ingredients: terbutaline, a bronchodilator that relaxes airway muscles; bromhexine, a mucolytic agent that breaks down thick mucus; guaifenesin, an expectorant that promotes the clearance of mucus; and menthol, which provides a soothing effect on the throat. This formulation is designed to facilitate easier breathing and effective expectoration in patients with respiratory congestion. It is distributed in India through a PCD (Propaganda Cum Distribution) franchise model.

Brand names
Vocuff-BR
02

Targets

TRPV3 (Transient receptor potential vanilloid subtype 3)ADRB2 (β2)ADRB1 (β1)ADRB3 (β3)TRPA1 (Transient receptor potential cation channel subfamily A member 1)

Beyond the preview

Go deeper on terbutaline + bromhexine + guaifenesin + menthol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on terbutaline + bromhexine + guaifenesin + menthol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call